Showing results (171-180 of 228) with videos related to
Sort By:
Pageof 23
JACC. Cardiovascular Interventions|April 20, 2010
Stunning and cumulative left ventricular dysfunction occurs late after coronary balloon occlusion in humans insights from simultaneous coronary and left ventricular hemodynamic assessmentStephen P Hoole, Patrick M Heck, Paul A White, et al.JACC. Cardiovascular Interventions|August 22, 2020
Assessment of Vascular Dysfunction in Patients Without Obstructive Coronary Artery Disease: Why, How, and WhenThomas J Ford, Peter Ong, Udo Sechtem, et al.Circulation|May 3, 2014
Effects of sex on coronary microvascular dysfunction and cardiac outcomesVenkatesh L Murthy, Masanao Naya, Viviany R Taqueti, et al.Journal of Clinical Medicine|September 9, 2023
Sex Differences in Quality of Life in Patients with Ischemia with No Obstructive Coronary Artery Disease (INOCA): A Patient Self-Report Retrospective Survey from INOCA InternationalSachini Ranasinghe, C Noel Bairey Merz, Najah Khan, et al.International Journal of Cardiology|December 13, 2018
Anti-anginal drugs: Systematic review and clinical implicationsRita Pavasini, Paolo G Camici, Filippo Crea, et al.European Heart Journal|March 17, 2005
Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of CardiologySigmund Silber, Per Albertsson, Francisco F Avilés, et al.Pacing and Clinical Electrophysiology : PACE|January 7, 2011
The impact of the right ventricular lead position on response to cardiac resynchronization therapyFakhar Z Khan, Pegah Salahshouri, Rudy Duehmke, et al.Journal of the American College of Cardiology|March 13, 2012
Targeted left ventricular lead placement to guide cardiac resynchronization therapy: the TARGET study: a randomized, controlled trialFakhar Z Khan, Mumohan S Virdee, Christopher R Palmer, et al.Journal of Cardiovascular Medicine (Hagerstown, Md.)|December 11, 2012
Methods to investigate coronary microvascular function in clinical practiceGaetano A Lanza, Paolo G Camici, Leonarda Galiuto, et al.JACC. Cardiovascular Interventions|February 22, 2015
Pre-treatment with glucagon-like Peptide-1 protects against ischemic left ventricular dysfunction and stunning without a detected difference in myocardial substrate utilizationLiam M McCormick, Stephen P Hoole, Paul A White, et al.Pageof 23